YH35995

· Yuhan Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YH35995, covering 2025-11-21 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-Human, Single- and Multiple-Ascending Dose Study of YH35995 in Healthy Adult Male Participants [Phase 1]

See pricing